Targeting the growth hormone axis as a therapeutic strategy in oncology

Print
Published on Wednesday, 01 July 2015

Targeting the growth hormone axis as a therapeutic strategy in oncology

 

 

About this publication.

 

See also:

- Somatostatin in oncology, the overlooked evidences in the "Some additional publications about hGH/GH-GHRH/GHRF/GRF" section.